DVBB2D1 Evera XT
Implantable Cardioverter Defibrillator (ICD)
DVBB2D1 Evera XT
Information

Device Survival Probability

EVERA_VR_SURV
Loading...










    1 yr 2 yr 3 yr 4 yr 5 yr 6 yr 7 yr 8 yr 9 yr 10 yr at 124.0 mo                    
% Excluding Normal Battery Depletion 100.0 100.0 99.9 99.8 99.8 99.6 99.6 99.5 99.4 99.3 99.3                    
% Including Normal Battery Depletion 100.0 99.9 99.7 99.6 99.4 99.1 98.9 98.7 98.3 97.7 97.5                    
#   52431 48794 45402 42247 39173 36002 33070 26184 13541 3207 436                    
  • Including Normal Battery Depletion – This curve includes devices that have reached at least 80% of expected longevity. This curve is most representative of clinical performance and how long the device will last.
  • Excluding Normal Battery Depletion – This is the malfunction free survival curve.
Information

Product Characteristics

Generator Type ICD
NBD Code VVE-VVIR
Max. Delivered Energy 36 J
More
Connector Style Cx Style
Serial Number Prefix BWK
Mass 77 g
Volume 33 cc
Waveform Biphasic
X-Ray ID PXT
Hide this content
Cx Style
Information

Estimated Longevity

Charging Frequency 100% Pacing 50% Pacing 15% Pacing 100% Sensing
Monthly 4.9 5.3 5.7 5.8
Quarterly 7.8 8.8 9.7 10.1
Semi-annual 8.5 9.7 10.7 11.3
Footnote

Longevity estimates based on the following device usage. Pacing Mode VVI; Ventricular Lower Pacing Rate 60ppm; Ventricular Pulse Width 0.4ms; Ventricular Pulse Amplitude 3V; Ventricle Impedance 510ohms; Ventricle Sensing Rate 70bpm; EGM prestorage OFF; Optivol ON; Charging frequency assumes maximum energy charge and includes therapy shocks and capacitor formation. Hide this content

Information

Distribution Data

US Market Release
CE Approval Date2012-12-17
Registered USA Implants
Estimated Active USA Implants
Normal Battery Depletions
US Market Release
CE Approval Date2012-12-17
Estimated WW Distribution16781
Normal Battery Depletions2
Information

Malfunctions (USA)

Therapy Function Not Compromised
Therapy Function Compromised
Information

Malfunctions (WW)

Therapy Function Not Compromised 16
Battery 14
Electrical Component 2
Therapy Function Compromised 10
Battery 8
Device-Related Current Pathway 2
Information

EOS Indication

From the point that the RRT is set, the pacemaker will operate for approximately three months for typical pacemaker configurations during the normal operating life.

Information

Recommended Replacement (RRT)

Battery voltage less than or equal to 2.73V on 3 consecutive daily automatic measurments.

Information

Charge Time

BLACKWELL_VR_CHRG
Loading...

Data as of April 30, 2024

www.medtronic.com/productperformance 1001052